Related Experiment Video
Updated: Sep 23, 2025
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
2.7K
Thrombosis, cancer, and COVID-19
Norman Brito-Dellan1, Nikolaos Tsoukalas2, Carme Font3
1Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030-4009, USA. nbrito@mdanderson.org.
Summary
Cancer patients face higher COVID-19 risks and thrombosis. This review covers managing cancer-associated thrombosis during COVID-19, emphasizing vaccination and anticoagulation therapy.
Area of Science:
- Oncology
- Infectious Diseases
- Hematology
Background:
- Cancer and COVID-19 share risks like thrombosis and high D-dimer levels.
- Cancer patients exhibit increased vulnerability and mortality from COVID-19.
- SARS-CoV-2 research has rapidly advanced treatment and vaccine development.
Purpose of the Study:
- To review current data on cancer-associated thrombosis (CAT) and COVID-19.
- To discuss management strategies for CAT in COVID-19 patients.
- To highlight considerations for COVID-19 vaccination in cancer patients.
Main Methods:
- Literature review of studies on cancer, COVID-19, thrombosis, and vaccines.
- Analysis of clinical data regarding thrombosis management in cancer patients with COVID-19.
- Examination of recommendations for COVID-19 vaccination in immunocompromised cancer patients.
Main Results:
- Cancer patients are prioritized for COVID-19 vaccination but may have a diminished immune response.
- Additional vaccine doses and boosters are recommended for cancer patients undergoing treatment.
- Anticoagulation therapy remains the primary treatment for thrombosis in cancer patients with COVID-19.
Conclusions:
- Effective management of cancer-associated thrombosis in COVID-19 requires a multifaceted approach.
- COVID-19 vaccination is crucial for cancer patients, with specific protocols for enhanced immunity.
- Continued research is needed to optimize treatment and prevention strategies for this vulnerable population.
More Related Videos
Related Concept Videos
01:30Venous Thrombosis I: Introduction
49
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
49
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
943
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
943
01:29Venous Thrombosis III: Interprofessional Care
33
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
33
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
02:18Cancer
50.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
50.0K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K